News

Altimmune Set to Showcase Innovations at Key Conferences

Altimmune Set to Showcase Innovations at Key Conferences

Altimmune's Upcoming Investor Conferences

GAITHERSBURG, Md. — Altimmune, Inc. (Nasdaq: ALT), a biopharmaceutical company known for its innovative peptide-based therapeutics targeting liver and cardiometabolic diseases, has exciting news. Members of Altimmune's management team will be attending two notable investor conferences where they will engage in discussions, including one-on-one meetings with interested parties.

Details of the Conferences

Stifel 2025 Virtual Cardiometabolic Forum

The first conference, the Stifel 2025 Virtual Cardiometabolic Forum, is scheduled for a fireside chat on Tuesday, September 30, 2025 at 10:30 a.m. Eastern Time. This platform provides an excellent opportunity for investors to gain insights into Altimmune’s strategies and developments.

H.C. Wainwright Liver Disease Virtual Conference

Following closely is the H.C. Wainwright Liver Disease Virtual Conference on Tuesday, October 21, 2025 at 7:00 a.m. Eastern Time. This forum will further highlight Altimmune's commitment to addressing liver diseases and the therapeutic advancements they are making.

Accessing the Conference Sessions

For those unable to attend these events live, the sessions will be available via webcast. Interested parties can access these webcasts by visiting the Events section on the Altimmune website.

About Altimmune and Its Lead Product

Altimmune, Inc. is not just another biopharmaceutical player; it focuses on pioneering peptide-based therapeutics that cater to critical health issues such as liver and cardiometabolic diseases. Their leading product candidate, pemvidutide, works as a dual receptor agonist, making strides in treating Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD), Alcohol-associated Liver Disease (ALD), and obesity.

The Impact of Altimmune's Innovations

The work being done at Altimmune is crucial as it addresses significant health concerns in today's society. The company's innovative approach to therapeutic development sets it apart in a competitive industry, aiming to provide effective treatment solutions for patients facing serious health challenges.

Stay Connected with Altimmune

For ongoing updates, you can follow Altimmune on LinkedIn and X to stay informed about their journey, breakthroughs, and participation in various events such as these conferences.

Investor Contact Information

For more information, investors can reach out to Lee Roth from Burns McClellan at 646-382-3403 or contact him via email.

Frequently Asked Questions

What is the focus of Altimmune?

Altimmune specializes in developing peptide-based therapeutics for liver and cardiometabolic diseases.

When are the upcoming investor conferences?

The Stifel 2025 Virtual Cardiometabolic Forum is on September 30, 2025, and the H.C. Wainwright Liver Disease Virtual Conference is on October 21, 2025.

How can I access the conference sessions?

The sessions will be webcast and can be accessed through the Events section of Altimmune's website.

What is pemvidutide?

Pemvidutide is Altimmune's leading product candidate, functioning as a dual receptor agonist for treating various metabolic diseases.

Who can I contact for more information?

Investors can contact Lee Roth at Burns McClellan for details and inquiries regarding Altimmune.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LUNGevity's Bold $1M Bet on Lung Cancer Research

Updated Category News Views 50

Investing in the Future of Lung Cancer Research Damn, you don't see this kind of commitment every day! LUNGevity Foundation is dropping over a million bucks on the table to swell the ranks of lung cancer researchers. They're not just tossing dollars at established players; they're betting on fresh minds to shake things up in this critical field. Tackling lung cancer isn't...

Continue Reading
Xylem Investigation: Legal Drama Unfolds for Investors

Updated Category News Views 0

Riding the Waves of Xylem's Share Shocks Xylem Inc. put shareholders on a dizzying rollercoaster, adjusting its earnings expectations in a way that’s left plenty of investors fuming. Back in July, the company hyped up its 2026 earnings outlook, only to slash it three months later in October. For folks holding bags of NYSE:XYL, this abrupt shift is more than a numbers...

Continue Reading
oToBrite Unveils Avant-Garde Robotics Vision Tech at ROBOTWORLD

Updated Category News Views 133

An Eye on the Future: oToBrite's Bold Vision for Robotics Strolling down the aisles at ROBOTWORLD 2026, there's a palpable energy buzzing around oToBrite's booth. These folks are showcasing vision technology that's not just about snapping slick photos—it's about reshaping how machines see the world. And, let me tell you, if there’s one place to flaunt cutting-edge...

Continue Reading
DERMALOG Bolsters Biometric Defense with Key Wins

Updated Category News Views 74

DERMALOG Rides High with PAD Success Germany-based DERMALOG just gave biometric crooks a run for their money. In a testament to gutsy tech work, they've hit a homerun with the latest independent security evaluations. They’ve managed to spot and shut down all 1,500 tried and tested spoofs in presentation attacks—think photos, videos, and phony fingerprints. That’s no...

Continue Reading
Fed Holds Steady, But CD Rates Climb: Savers' Edge

Updated Category News Views 76

The Fed Sits Tight, But CD Rates Surge Isn't it a kicker when the Fed holds rates steady, yet the CD market is buzzing like a crowded trading floor on a bull run? We've seen the Federal Reserve hold its ground without budging interest rates, keeping everyone guessing while inflation's still a shadow in the corner. But the star of the show here isn't the Fed's poker...

Continue Reading
Envision Energy's AI System Targets Green Mining Future

Updated Category News Views 96

The New Frontier: Mining's Green Shift Mining's bustling heart might just get an eco-friendly tune-up. That's the buzz Envision Energy stoked at All Energy Australia with their new AI-powered energy system aimed squarely at the mining and smelting industry. With wind, solar, battery storage, and all kinds of renewable gimmicks, they're striving to make those hulking...

Continue Reading
Singapore's New Leap in Healthcare Innovation with IMDA-NUH Partnership

Updated Category News Views 66

A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...

Continue Reading
Ryde Group Faces Class Action: Key Investor Takeaways

Updated Category News Views 22

Ryde Group's Tumble: More Than Just Market Volatility When RYDE shares nosedived like a lead balloon, it wasn't due to a market hiccup—it was a darn mess fueled by alleged manipulation. At the heart of this crash are accusations of a blatant pump-and-dump scheme that allegedly swindled investors out of millions. Pump-and-Dump: The Dirty Mechanics This ain't your regular...

Continue Reading
Jamaica's Tourism Rebounds Post-Hurricane Challenges

Updated Category News Views 103

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Continue Reading
2021 Ferrari Portofino Shines Bright at Jake's Motorcars

Updated Category News Views 67

San Diego might be known for its sunny weather, but Jake's Motorcars just cranked the heat with a 2021 Ferrari Portofino that flaunts a special-ordered Mandarin Orange interior. Now, if that doesn't scream "look at me," I don't know what does. For those who aren't just dabbling in Ferraris but are downright obsessed, let's dig into what makes this sports car not just...

Continue Reading

Top 5 Most Recently Viewed Articles

AI Market Shakeup: Rivals Surpass Nvidia Gains in 2025

Updated Category News Views 328

The AI Market Landscape in 2025 The artificial intelligence (AI) market, which has been largely dominated by Nvidia Corp. (NASDAQ: NVDA), appears to be undergoing significant changes as new players in the semiconductor industry are now outperforming the leader. This shift reflects a broader investor interest in various segments of the AI hardware stack, moving away from a...

Continue Reading
Hannah Brooke Takes Helm as Head of Marine Cargo at HDI

Updated Category News Views 484

Strategic Leadership in Marine Cargo Underwriting HDI Global has announced a significant leadership change with the appointment of Hannah Brooke as the new Head of Marine Cargo Underwriting for the UK and Ireland. Starting from January 1, 2025, Brooke is set to enhance the company's Marine Cargo operations, focusing on a robust growth strategy. Background of Hannah Brooke...

Continue Reading
Altimmune Set to Showcase Innovations at Key Conferences

Updated Category News Views 125

Altimmune's Upcoming Investor Conferences GAITHERSBURG, Md. — Altimmune, Inc. (Nasdaq: ALT), a biopharmaceutical company known for its innovative peptide-based therapeutics targeting liver and cardiometabolic diseases, has exciting news. Members of Altimmune's management team will be attending two notable investor conferences where they will engage in discussions,...

Continue Reading
Celebrating Skilled Trades: A New Era for Canadian Youth

Updated Category News Views 145

Celebrating the National Skilled Trade and Technology Week OTTAWA, Ontario - Skills/Compétences Canada (SCC) proudly honors the National Skilled Trade and Technology Week (NSTTW), which serves to enlighten students and educators about the vast career opportunities in skilled trades across Canada. Interactive Events Focused on Skills Development On this special occasion,...

Continue Reading
Understanding Voting Rights and Their Impact on Shareholders

Updated Category News Views 257

Key Insights into Voting Rights ICG Enterprise Trust plc aims to keep its shareholders informed about significant aspects of governance, including the vital area of voting rights. These rights play an essential role in corporate democracy, enabling shareholders to express their opinions on crucial company decisions. Current Voting Rights Overview As of the end of December...

Continue Reading